Skip to main content
. 2015 Apr 26;10:103. doi: 10.1186/s13014-015-0393-9

Table 5.

Univariate analysis of factors associated with RT-BOOT symdrome

ALL (n = 1176) BCT (n = 948) PMRT (n = 228)
Parameter Level n (%) Incidence of BOOP syndrome, n (%) p n (%) Incidence of BOOP syndrome, n (%) p n (%) Incidence of BOOP syndrome, n (%) p
Age <52y* 559 (48) 3 (0.5) 0.023 457 (48) 2 (0.4) 0.039 102 (45) 1 (1.0) 0.63
>-52y 617 (52) 13 (2.1) 491 (52) 10 (2.0) 126 (55) 3 (2.4)
OneSide One side 1157 (98) 16 (1.4) 1.00 929 (98) 12 (1.3) 1.00 228 (100) 4 (1.8) -
Bilateral 19 (2) 0 (0.0) 19 (2) 0 (0.0) 0 (0) 0 (0)
Allergy Yes 400 (34) 6 (1.5) 0.79 328 (35) 5 (1.5) 0.76 72 (32) 1 (1.4) 1.00
No 775 (66) 10 (1.3) 619 (65) 7 (1.1) 156 (68) 3 (1.9)
Unkonwn 1 (0) 0 (0.0) 1 (0) 0 (0.0) 0 (0) 0 (0.0)
Smoking Yes 201 (17) 5 (2.5) 0.17 147 (16) 4 (2.7) 0.10 54 (24) 1 (1.9) 1.00
No 973 (83) 11 (1.1) 800 (84) 8 (1.0) 173 (76) 3 (1.7)
Unkonwn 2 (0) 0 (0.0) 1 (0) 0 (0.0) 1 (0) 0 (0.0)
Chemotherapy Yes 607 (52) 6 (1.0) 0.32 389 (41) 2 (0.5) 0.14 218 (96) 4 (1.8) 1.00
No 569 (48) 10 (1.8) 559 (59) 10 (1.8) 10 (4) 0 (0.0)
ET Yes 796 (68) 13 (1.6) 0.29 635 (67) 11 (1.7) 0.12 161 (71) 2 (1.2) 0.58
No 380 (32) 3 (0.8) 313 (33) 1 (0.3) 67 (29) 2 (3.0)
RT Yes 765 (96) 13 (1.7) 1.00 614 (97) 11 (1.8) 1.00 151 (94) 2 (1.3) 1.00
No 31 (4) 0 (0.0) 21 (3) 0 (0.0) 10 (6) 0 (0.0)
Trastuzumab Yes 68 (6) 2 (2.9) 0.24 35 (4) 0 (0.0) 1.00 33 (14) 2 (6.1) 0.10
No 1108 (94) 14 (1.3) 913 (96) 12 (1.3) 195 (86) 2 (1.0)
Treatment BCT 948 (81) 12 (1.3) 0.53 - - - - - -
PMRT 228 (19) 4 (1.8)
Boost Yes 963 (82) 13 (1.3) 1.00 902 (95) 12 (1.3) 1.00 61 (27) 1 (1.6) 1.00
No 213 (18) 3 (1.4) 46 (5) 0 (0.0) 167 (73) 3 (1.8)
Irradiation to the regional LNs Yes 269 (23) 4 (1.5) 0.77 58 (6) 0 (0.0) 1.00 211 (93) 4 (1.9) 1.00
No 907 (77) 12 (1.3) 890 (94) 12 (1.3) 17 (7) 0 (0.0)
Lung V20 0-4.9% 280 (24) 2 (0.7) 0.19 274 (29) 2 (0.7) 0.62 6 (3) 0 (0.0) 0.32
5.0-9.9% 620 (53) 10 (1.6) 586 (62) 10 (1.7) 34 (15) 0 (0.0)
10.0-14.9% 166 (14) 1 (0.6) 62 (7) 0 (0.0) 104 (46) 1 (1.0)
15.0-19.9% 93 (8) 2 (2.2) 22 (2) 0 (0.0) 71 (31) 2 (2.8)
20.0-24.9% 14 (1) 1 (7.1) 2 (0) 0 (0.0) 12 (5) 1 (8.3)
25.0-29.9% 0 (0) 0 (0.0) 0 (0) 0 (0.0) 0 (0) 0 (0.0)
30.0-34.9% 1 (0) 0 (0.0) 1 (0) 0 (0.0) 0 (0) 0 (0.0)
Unkonwn 2 (0) 0 (0.0) 1 (0) 0 (0.0) 1 (0) 0 (0.0)

P: by Fisher’s exact test.

*: median of age.

Abbreviations

BOOP Bronchiolitis obliterans organizing pneumonia.

ET Endocrine therapy.

RT Radiation therapy.

LNs Lymph nodes.

BCT Breast conserving therapy.

PMRT Postmastectomy radiation therapy.